Task Force Recommends Against PSA-Based Screening For Prostate Cancer: Evidence Show Harms Of PSA Testing Outweigh The Benefits
Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age. The final recommendations are being published early online in the May 22 issue of Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP). The Task Force last published recommendations on prostate cancer screening in 2008... (Source: Health News from Medical News Today)

Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval To Market Generic Glucotrol(R)
Caraco PharmaceuticalLaboratories, Ltd., (Amex: CPD) announced today that the U.S. Food and DrugAdministration (FDA) has granted final approval for the Company'sAbbreviated New Drug Application (ANDA) for Glipizide tablets. [click link for full article] (Source: Health News from Medical News Today)